173 related articles for article (PubMed ID: 16920726)
1. Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers.
Hoei-Hansen CE; Carlsen E; Jorgensen N; Leffers H; Skakkebaek NE; Rajpert-De Meyts E
Hum Reprod; 2007 Jan; 22(1):167-73. PubMed ID: 16920726
[TBL] [Abstract][Full Text] [Related]
2. A novel double staining strategy for improved detection of testicular carcinoma in situ cells in human semen samples.
Nielsen JE; Kristensen DM; Almstrup K; Jørgensen A; Olesen IA; Jacobsen GK; Horn T; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Andrologia; 2012 Apr; 44(2):78-85. PubMed ID: 21486421
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
[TBL] [Abstract][Full Text] [Related]
4. A subfertile patient diagnosed with testicular carcinoma in situ by immunocytological staining for AP-2gamma in semen samples: case report.
Hoei-Hansen CE; Rajpert-De Meyts E; Carlsen E; Almstrup K; Leffers H; Skakkebaek NE
Hum Reprod; 2005 Mar; 20(3):579-82. PubMed ID: 15650041
[TBL] [Abstract][Full Text] [Related]
5. Application of stem cell markers in search for neoplastic germ cells in dysgenetic gonads, extragonadal tumours, and in semen of infertile men.
Hoei-Hansen CE
Cancer Treat Rev; 2008 Jun; 34(4):348-67. PubMed ID: 18289797
[TBL] [Abstract][Full Text] [Related]
6. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours.
Hoei-Hansen CE; Almstrup K; Nielsen JE; Brask Sonne S; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Histopathology; 2005 Jul; 47(1):48-56. PubMed ID: 15982323
[TBL] [Abstract][Full Text] [Related]
7. Screening of subfertile men for testicular carcinoma in situ by an automated image analysis-based cytological test of the ejaculate.
Almstrup K; Lippert M; Mogensen HO; Nielsen JE; Hansen JD; Daugaard G; Jørgensen N; Foged NT; Skakkebaek NE; Rajpert-De Meyts E
Int J Androl; 2011 Aug; 34(4 Pt 2):e21-30; discussion e30-1. PubMed ID: 21696398
[TBL] [Abstract][Full Text] [Related]
8. Stem cell factor as a novel diagnostic marker for early malignant germ cells.
Stoop H; Honecker F; van de Geijn GJ; Gillis AJ; Cools MC; de Boer M; Bokemeyer C; Wolffenbuttel KP; Drop SL; de Krijger RR; Dennis N; Summersgill B; McIntyre A; Shipley J; Oosterhuis JW; Looijenga LH
J Pathol; 2008 Sep; 216(1):43-54. PubMed ID: 18566970
[TBL] [Abstract][Full Text] [Related]
9. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
[TBL] [Abstract][Full Text] [Related]
10. Current approaches for detection of carcinoma in situ testis.
Hoei-Hansen CE; Olesen IA; Jorgensen N; Carlsen E; Holm M; Almstrup K; Leffers H; Rajpert-De Meyts E
Int J Androl; 2007 Aug; 30(4):398-404; discussion 404-5. PubMed ID: 17705812
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of extragonadal seminomas.
Biermann K; Klingmüller D; Koch A; Pietsch T; Schorle H; Büttner R; Zhou H
Histopathology; 2006 Sep; 49(3):290-7. PubMed ID: 16918976
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors.
Pauls K; Jäger R; Weber S; Wardelmann E; Koch A; Büttner R; Schorle H
Int J Cancer; 2005 Jun; 115(3):470-7. PubMed ID: 15700319
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours.
de Jong J; Stoop H; Dohle GR; Bangma CH; Kliffen M; van Esser JW; van den Bent M; Kros JM; Oosterhuis JW; Looijenga LH
J Pathol; 2005 Jun; 206(2):242-9. PubMed ID: 15818593
[TBL] [Abstract][Full Text] [Related]
14. Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors.
Iczkowski KA; Butler SL; Shanks JH; Hossain D; Schall A; Meiers I; Zhou M; Torkko KC; Kim SJ; MacLennan GT
Hum Pathol; 2008 Feb; 39(2):275-81. PubMed ID: 18045648
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in alkaline phosphatase isozyme expression in human testicular germ cell tumours: An enzyme-/immunohistochemical and molecular analysis.
Roelofs H; Manes T; Janszen T; Millán JL; Oosterhuis JW; Looijenga LH
J Pathol; 1999 Oct; 189(2):236-44. PubMed ID: 10547581
[TBL] [Abstract][Full Text] [Related]
17. Expression of the PDGF alpha-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues. Implications for the early diagnosis of testicular germ cell tumours and for our understanding of regulatory mechanisms.
Palumbo C; van Roozendaal K; Gillis AJ; van Gurp RH; de Munnik H; Oosterhuis JW; van Zoelen EJ; Looijenga LH
J Pathol; 2002 Apr; 196(4):467-77. PubMed ID: 11920744
[TBL] [Abstract][Full Text] [Related]
18. A novel cell-processing method 'AgarCytos' in conjunction with OCT3/4 and PLAP to detect intratubular germ cell neoplasia in non-obstructive azoospermia using remnants of testicular sperm extraction specimens.
Hessel M; Ramos L; Hulsbergen AF; D'Hauwers KW; Braat DD; Hulsbergen-van de Kaa CA
Hum Reprod; 2013 Oct; 28(10):2608-20. PubMed ID: 23900208
[TBL] [Abstract][Full Text] [Related]
19. Fibrillin-1 (FBN-1) a new marker of germ cell neoplasia in situ.
Cierna Z; Mego M; Jurisica I; Machalekova K; Chovanec M; Miskovska V; Svetlovska D; Kalavska K; Rejlekova K; Kajo K; Mardiak J; Babal P
BMC Cancer; 2016 Aug; 16():597. PubMed ID: 27487789
[TBL] [Abstract][Full Text] [Related]
20. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy.
Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S
Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
